FindTrial
Sign In

A prospective study of the correlation between glycosylated hemoglobin and contrast induced nephropathy

A prospective study of the correlation between glycosylated hemoglobin and contrast induced nephropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17011466
Enrollment
Unknown
Registered
2017-05-23
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast induced nephropathy

Interventions

Case series :None

Sponsors

Zhongda Hospital of Southeast University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) volunteered to participate in this trial and signed informed consent; (2) Aged more than 18 Years; (3) Suspected as Coronary heart disease and Planned to execute Coronary angiography;

Exclusion criteria

Exclusion criteria: (1) Hypersensitivity to iodine-containing compounds; (2) CKD stages 5 (eGFR<15ml/min per 1.73m2)or under Maintenance hemodialysis; (3) acute ST-segment elevation myocardial infarction (STEMI); (4) NYHA class IV or hemodynamic instability; (5) Take CT, MRI and other examinations with contrast agents during the two weeks before study; take radiographic examination of other contrast agents during the study period;

Design outcomes

Primary

MeasureTime frame
glycosylated hemoglobin;—

Countries

China

Contacts

Public ContactChengchun Tang

Department of Cardiology, Zhongda Hospital of Southeast University Medical School

tangchengchun@medmail.com.cn+86 13914705570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026